{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:51:07Z","timestamp":1790257867621,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.intimp.2016.08.005","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T21:00:24Z","timestamp":1472158824000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Expression profile of cytokines and chemokines in osteoarthritis patients: Proinflammatory roles for CXCL8 and CXCL11 to chondrocytes"],"prefix":"10.1016","volume":"40","author":[{"given":"Peng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.08.005_bb0005","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMcp051726","article-title":"Clinical practice. Osteoarthritis of the knee","volume":"354","author":"Felson","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2016.08.005_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcna.2008.08.009","article-title":"Etiopathogenesis of osteoarthritis","volume":"93","author":"Brandt","year":"2009","journal-title":"Med. Clin. North. Am."},{"key":"10.1016\/j.intimp.2016.08.005_bb0015","first-page":"95","article-title":"Effects of shear stress on articular chondrocyte metabolism","volume":"37","author":"Lane Smith","year":"2000","journal-title":"Biorheology"},{"key":"10.1016\/j.intimp.2016.08.005_bb0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.joca.2005.01.005","article-title":"Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis \u2013 results of a 1year longitudinal arthroscopic study in 422 patients","volume":"13","author":"Ayral","year":"2005","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2016.08.005_bb0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CDLI.5.4.430-437.1998","article-title":"T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis","volume":"5","author":"Sakkas","year":"1998","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.intimp.2016.08.005_bb0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(97)07226-7","article-title":"Osteoarthritis","volume":"350","author":"Creamer","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2016.08.005_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bone.2012.02.012","article-title":"The role of synovitis in osteoarthritis pathogenesis","volume":"51","author":"Scanzello","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.intimp.2016.08.005_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1759720X12467868","article-title":"Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations","volume":"5","author":"Sokolove","year":"2013","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.intimp.2016.08.005_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clim.2012.12.011","article-title":"Immunopathogenesis of osteoarthritis","volume":"146","author":"Haseeb","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2016.08.005_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2016.08.005_bb0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/11319950-000000000-00000","article-title":"Anticytokine therapy for osteoarthritis: evidence to date","volume":"27","author":"Malemud","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.intimp.2016.08.005_bb0060","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/art.10496","article-title":"Detection of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1","volume":"46","author":"Loeser","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2016.08.005_bb0065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/art.20776","article-title":"Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage","volume":"52","author":"Kobayashi","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2016.08.005_bb0070","doi-asserted-by":"crossref","first-page":"39762","DOI":"10.1074\/jbc.M303541200","article-title":"Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes","volume":"278","author":"Chadjichristos","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2016.08.005_bb0075","first-page":"818","article-title":"The effect of human interleukin 1 on proteoglycan metabolism in human and porcine cartilage explants","volume":"17","author":"Nietfeld","year":"1990","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2016.08.005_bb0080","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","article-title":"OARSI guidelines for the non-surgical management of knee osteoarthritis","volume":"22","author":"McAlindon","year":"2014","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2016.08.005_bb0085","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/ar3555","article-title":"Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4","volume":"14","author":"Sohn","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2016.08.005_bb0090","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/ar2172","article-title":"High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis","volume":"9","author":"Gobezie","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2016.08.005_bb0095","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.joca.2007.06.006","article-title":"Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA","volume":"16","author":"Chen","year":"2008","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2016.08.005_bb0100","first-page":"65","article-title":"Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8","volume":"110","author":"Attur","year":"1998","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"10.1016\/j.intimp.2016.08.005_bb0105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/ard.2002.003749","article-title":"Tenascin and aggrecan expression by articular chondrocytes is influenced by interleukin 1beta: a possible explanation for the changes in matrix synthesis during osteoarthritis","volume":"63","author":"Pfander","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2016.08.005_bb0110","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.joca.2010.08.003","article-title":"Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cells","volume":"18","author":"Endres","year":"2010","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2016.08.005_bb0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/ten.a.2007.0121","article-title":"Expression of CXC chemokines and their receptors is modulated during chondrogenic differentiation of human mesenchymal stem cells grown in three-dimensional scaffold: evidence in native cartilage","volume":"14","author":"Cristino","year":"2008","journal-title":"Tissue Eng. Part. A."},{"key":"10.1016\/j.intimp.2016.08.005_bb0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00005-011-0115-4","article-title":"CXCL8 and CCL5 expression in synovial fluid and blood serum in patients with osteoarthritis of the knee","volume":"59","author":"Pierzchala","year":"2011","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.intimp.2016.08.005_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.12589","article-title":"CCL2, CXCL8, CXCL9 and CXCL10 serum levels increase with age but are not altered by treatment with hydroxychloroquine in patients with osteoarthritis of the knees","author":"Bonfante","year":"2015","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.intimp.2016.08.005_bb0130","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1189\/jlb.1003524","article-title":"Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids","volume":"75","author":"Proost","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2016.08.005_bb0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.clbc.2012.03.006","article-title":"Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression","volume":"12","author":"Razis","year":"2012","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.intimp.2016.08.005_bb0140","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1210\/en.2010-1481","article-title":"Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes","volume":"152","author":"Kanda","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.intimp.2016.08.005_bb0145","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1158\/1541-7786.MCR-12-0518","article-title":"EpCAM modulates NF-kappaB signaling and interleukin-8 expression in breast cancer","volume":"11","author":"Sankpal","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.intimp.2016.08.005_bb0150","first-page":"L790","article-title":"Airway smooth muscle CXCR3 ligand production: regulation by JAK-STAT1 and intracellular Ca(2)(+)","volume":"304","author":"Tan","year":"2013","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916303228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916303228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T22:22:17Z","timestamp":1657146137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916303228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":30,"alternative-id":["S1567576916303228"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.08.005","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression profile of cytokines and chemokines in osteoarthritis patients: Proinflammatory roles for CXCL8 and CXCL11 to chondrocytes","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}